| Literature DB >> 21197437 |
E Ypsilantis1, H Charfare, W S Wassif.
Abstract
Background. Minimally invasive parathyroidectomy (MIP) is increasingly replacing the traditional bilateral neck exploration in the treatment of primary hyperparathyroidism (PHP). Intraoperative PTH (IOPTH) measurement has recently been introduced as a useful adjunct in confirming successful excision of abnormal parathyroid gland. Aims. We evaluate the safety, efficacy, and clinical usefulness of IOPTH measurement during MIP in a district general hospital. Methods. Retrospective review of eleven consecutive patients with PHP who underwent MIP with IOPTH, following preoperative assessment with ultrasound and sestamibi scans. Results. All patients had successful removal of the abnormal parathyroid gland. The concordance rate between ultrasound and sestamibi scan in localising the parathyroid adenoma was 82%. IOPTH measurement confirmed the removal of adenoma in all cases and, in one case, led to identification of a second adenoma, not localised preoperatively. The median hospital stay was 2 days (range 1-7 days). All patients remained normocalcaemic after a median of 6 months (range 1-10 months). Conclusions. Minimally invasive parathyroidectomy is a feasible, safe, and effective method for treatment of PHP. The use of IOPTH monitoring potentially offers increased sensitivity in detecting multiglandular disease, can minimise the need and risk associated with recurrent operations, and may facilitate cost-effective minimally invasive surgery.Entities:
Year: 2010 PMID: 21197437 PMCID: PMC3010640 DOI: 10.1155/2010/178671
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Patient characteristics, preoperative and postoperative serum calcium, and parathormone levels.
| Patient characteristics | ||||
|---|---|---|---|---|
| Median | Range | |||
| Age | ||||
|
| ||||
| Serum vitamin D | 61 | 46–67 | ||
| 26 | 16–35 | |||
| Gender | N | % | ||
|
| ||||
|
| 2 | 18 | ||
|
| 9 | 82 | ||
| Operation | ||||
|
| ||||
|
| 10 | 91 | ||
|
| 1 | 9 | ||
| Patients | Preop PTH | Preop serum Ca | Postop PTH | Postop serum Ca |
|
| ||||
|
| 154 | 3.13 | 75 | 2.63 |
|
| 1059 | 6.06 | 28 | 2.32 |
|
| 1924 | 3.61 | 162 | 2.23 |
|
| 86 | 2.70 | 43 | 2.32 |
|
| 44 | 3.07 | 20 | 2.33 |
|
| 697 | 3.82 | 14 | 2.25 |
|
| 142 | 2.91 | 68 | 2.26 |
|
| 367 | 4.00 | 10 | 2.85 |
|
| 194 | 2.90 | 92 | 2.29 |
|
| 249 | 3.14 | 42 | 2.3 |
|
| 120 | 2.90 | 47 | 2.45 |
Figure 1Serum PTH concentrations during the Intraoperative period of minimally invasive parathyroidectomy and at follow up, expressed as percentage difference from the baseline value (T0). T0 represents time of sample taken immediately after resection of adenoma and then at every 5 minutes up to 15 minutes (T5, T10, and T15). T0' represents time of sample taken immediately after resection of a second adenoma and then every 5 minutes for 15 minutes (T5', T10', and T15'). Follow up samples were organised after a median (range) of 6 (1–10) months.